Valuation (64%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 28.35 | 31.41 |
PEG Ratio (TTM) | 6.11 | -1.15 |
P/S Ratio (TTM) | 1.67 | 4.63 |
P/B Ratio (TTM) | 3.70 | 6.16 |
P/FCF Ratio (TTM) | 21.65 | 34.24 |
Price to 5YR AVG Earnings Ratio | 42.69 | 47.92 |
Price to 5YR AVG FCF Ratio | 45.35 | 55.24 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 5.08% | 9.04% |
ROE (TTM) | 13.54% | 21.95% |
Net Profit Margin (TTM) | 5.90% | 12.67% |
ROIC 5YR AVG | 10.76% | 21.30% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 8.01% | 17.32% | 19.80% |
Revenue | 1.02% | -2.53% | 2.80% |
Net Income | 8.11% | 19.99% | 21.75% |
Cash Flow | 362.21% | 14.57% | 168.39% |
Health (61%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.99 | 1.69 |
Quick Ratio (TTM) | 1.39 | 1.12 |
D/E Ratio (TTM) | 0.60 | 0.62 |
Interest Coverage (TTM) | 7.08 | 17.74 |
Piotroski F-Score | 7 | 7 |
Altman Z-Score | 3.93 | 5.35 |
LTL to 5YR AVG FCF | 7.72 | 6.05 |
Shares Outstanding Growth 5YR AVG | 0.11% | 0.41% |